Adeno-associated virus harboring fusion gene nt4-ant-shepherdin induce cell death in human lung cancer cells

Cancer Investigation

Volumn 28, Issue 5, 2010, Pages 465-471

  Xiaojiang, Tang ^a   Jinsong, Zhou ^b   Jiansheng, Wang ^a   Chengen, Pan ^c   Guangxiao, Yang ^d   Quanying, Wang ^d  

^a First Affiliated Hospital   (China)

^b Department of Anatomy Histology and Embryology ^*  (Hungary)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d Xi'an Huaguang Biological Engineering Co Ltd   (China)

Author keywords

Lung Cancer; Oncogenes; Therapy

Indexed keywords

HYBRID PROTEIN; NT4 ANTENNAPEDIA SHEPHERDIN FUSION PROTEIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

CASPASES; CELL DEATH; CELL LINE, TUMOR; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE GROWTH FACTORS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS;

EID: 77952224945     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903095706     Document Type: Article

References (25)

1. Ambrosini, G.; Adida, C.; Altieri, D.C. A novel anti-apoptosis gene survivin expressed in cancer and lymphama. J Nat Med 1997, 3(8), 917-921.
2. Altieri, D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003, 22(53), 8581-8589.
3. Falleni, M.; Pellegrini, C.; Marchetti, A.; Oprandi, B.; Buttitta, F.; Barassi, F.; Santambrogio, L.; Coggi, G.; Bosari, S. Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 2003, 200(5), 620-626.
4. Singhal, S.; Vachani, A.; Antin-Ozerkis, D.; Kaiser, L.R.; Albelda, S.M. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005, 11(11), 3974-3986.
5. Jiang, X.; Wilford, C.; Duensing, S.; Munger, K; Jones, G.; Jones, D. Participation of survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 2001, 83(2), 342-354.
6. Skonfias, D.A.; Mollinari, C.; Lacroix, F.B.; Margolis, R.L. Human survivin is a kinetochore-associated passenger protein. J Cell Biol 2000, 151(7), 1575-1582.
7. Blanc-Brude, O.P.; Mesri, M.; Wall, N.R.; Plescia, J.; Dohi, T.; Altieri, D.C. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumorassociated angiogenesis. Clin Cancer Res 2003,9(6), 2683-2692.
8. Zangemeister-Wittke, U. Antisense to apoptosis inhibitors facilitates chemotherapy and TRAIL-induced death signaling. Ann NY Acad Sci 2003, 1002, 90-94.
9. Wall, N.R.; O'Connor, D.S.; Plescia, J.; Pommier, Y.; Altieri, D.C. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res 2003, 63, 230-235.
10. Pennati, M.; Binda, M.; Colella, G.; Zoppe', M.; Folini, M.; Vignati, S.; Valentini, A.; Citti, L.; De Cesare, M.; Pratesi, G.; Giacca, M.; Daidone, M.G.; Zaffaroni. N. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene 2004, 23, 386-394.
11. Uchida, H.; Tanaka, T.; Sasaki, K.; Kato, K.; Dehari, H.; Tto, Y.; Kobune, M.; Miyagishi, M.; Taira, K.; Tahara, H.; Hamada, H. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004, 10, 162-171.
12. Siegel, S.;Wagner, A.; Schmitz, N.; Zeis, M. Induction of antiumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model. Br J Haematol 2003, 122, 911-914.
13. Xiang, R.; Mizutani, N.; Luo, Y.; Chiodoni, C.; Zhou, H,; Mizutani, M.; Ba, Y.; Becker, J.C.; Reisfeld, R.A. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 2005, 65, 553-561.
14. Chang, C.C.; Heller, J.D.; Kuo, J.; Huang, R.C. Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proc Natl Acad Sci USA 2004, 101, 13239-13244.
15. Fortugno, P.; Beltrami, E.; Plecia, J.; Fontana, J.; Pradhan, D.; Marchisio, P.C.; Sessa, W.C.; Altieri, D.C. Regulation of survivin function by Hsp90. PNAS 2003, 100(11), 13791-13796.
16. Plecia, J.; Salz, W.; Xia, F.; Pennati, M.; Zaffaroni, N.; Daidone, M.G.; Meli, M.; Dohi, T.; Fortugno, P.; Nefedova, Y.; Gabrilovich, D.I.; Colombo, G.; Altieri, D.C. Rational design of shepherdin, a novel anticancer agent. Cancer Cell 2005, 7(5), 457-468.
17. Bradford, M.M. A rapid and sensitive method for the quantitation of microgramquantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72, 248-254.
18. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
19. Jiang, X.;Wilford, C.; Duensing, S.; et al. Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 2001, 83(2), 342-354.
20. Smith, D.J.; Leil, T.A.; Liu, X. Neurotrophin-4 is required for tolerance to morphine in the mouse. Neurosci Lett 2003, 340(2), 103-106.
21. Timmusk, T.; Belluardo, N.; Metsis, M.; Persson, H. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci 1993, 5(6), 605-613.
22. Ip, N.Y.; Ibanez, C.F.; Nye, S.H.; McClain, J. Jones, P.P.; Gies, D.R.; Belluscio, L.; Le Beau, MM.; Espinosa, R. 3rd.; Squinto, S.P. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution receptor specificity. Proc Natl Acad Sci USA 1997, 89(7), 3060-3064.
23. Yu, Y.; Jiang, W.; Xin, Y.; Senglin, H. The construction of NT4 (Si)- NAP fusion gene vector and its expression in Ecoli. J Neurol 2004, 37(3), 260-261. (In Chinese)
24. Li, Y.; Qiu, S.; Song, L.; Yan, Q.; Yang, G. Secretory expression of p53(N15)-ant following lentivirus-mediated gene transfer induces cell death in human cancer cells. Cancer Invest 2008, 26, 28-34.
25. Flotte, T.R. Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2004, 11, 805-810.